Article Dans Une Revue Blood Advances Année : 2024

ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.

Marianne Courgeon
Ganna Panasyuk
Kathryn Wellen
Elizabeth Macintyre

Résumé

Alterations inactivating the tumor suppressor gene PTEN drive the development of solid and hematological cancers, such as T-cell acute lymphoblastic leukemia (T-ALL), whereby PTEN loss defines poor-prognosis patients. We investigated the metabolic rewiring induced by PTEN loss in T-ALL, aiming at identifying novel metabolic vulnerabilities. We showed that the enzyme ATP citrate lyase (ACLY) is strictly required for the transformation of thymic immature progenitors and for the growth of human T-ALL, which remain dependent on ACLY activity even upon transformation. Whereas PTEN mutant mice all died within 17 weeks, the concomitant ACLY deletion prevented disease initiation in 70% of the animals. In these animals, ACLY promoted BCL-2 epigenetic upregulation and prevented the apoptosis of pre-malignant DP thymocytes. Transcriptomic and metabolic analysis of primary T-ALL cells next translated our findings to the human pathology, showing that PTEN-altered T-ALL cells activate ACLY and are sensitive to its genetic targeting. ACLY activation thus represents a metabolic vulnerability with therapeutic potential for high-risk T-ALL patients.
Fichier principal
Vignette du fichier
bloodadvances.2024013762.pdf (7.57 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence

Dates et versions

hal-04910700 , version 1 (24-01-2025)

Licence

Identifiants

Citer

Guillaume P Andrieu, Guillaume Hypolite, Mehdi Latiri, Estelle Balducci, Caroline Costa, et al.. ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.. Blood Advances, 2024, ⟨10.1182/bloodadvances.2024013762/2313924/bloodadvances.2024013762.pdfbygueston⟩. ⟨hal-04910700⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More